Insider Holders & Insider Ownership - Xilio Therapeutics Inc. (XLO)

List of insiders holdings for Xilio Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
GILEAD SCIENCES INC.
10% Owner
2024-04-05 16:31:537,345,473
0
7,345,473Form 13G
SV7 Impact Medicine Fund LP
SV7 (IMF) GP LLP
10% Owner
2021-11-03 16:20:181,613,632
1,613,632
3,227,264Form 4/A
Rock Springs Capital Management LP
Rock Springs Capital LLC
Rock Springs Capital Master Fund LP
Four Pines Master Fund LP
10% Owner
2024-04-05 14:51:593,003,259
0
3,003,259Form 13G
Atlas Venture Fund XI L.P.
Atlas Venture Associates XI L.P.
Atlas Venture Associates XI LLC
Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates Opportunity I LLC
10% Owner
2024-02-09 16:33:082,019,563
734,546
2,754,109Form 4
FMR LLC
See Remark 1
2023-02-09 08:14:521,907,671
0
1,907,671Form 13G
TAKEDA PHARMACEUTICAL CO LTD
Takeda Ventures Inc.
10% Owner
2022-01-14 06:07:321,475,121
0
1,475,121Form 13G
RiverVest Venture Fund IV L.P.
10% Owner
2021-11-05 12:54:021,441,444
0
1,441,444Form 13D
Bain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Fund II L.P.
Bain Capital Life Sciences Investors II LLC
BCLS II Investco LP
BCLS II Investo (GP) LLC
BCIP Life Sciences Associates LP
10% Owner
2022-02-14 06:42:511,348,682
0
1,348,682Form 13G
BAY CITY CAPITAL LLC
10% Owner
2021-10-26 17:02:140
1,129,490
1,129,490Form 4
Merck KGaA
10% Owner
2021-10-26 17:06:330
680,825
680,825Form 4
Russo Rene
PRESIDENT AND CEO
2024-05-03 16:10:14474,000
0
474,000Form 4
LYNCH DANIEL
Director
10% Owner
2021-10-21 20:39:43335,394
0
335,394Form 3
FIL Ltd
See Remark 1
2021-10-28 15:57:550
218,705
218,705Form 4
Frankenfield Christopher James
CHIEF OPERATING OFFICER
2024-05-03 16:10:19208,000
0
208,000Form 4
Alexandria Venture Investments LLC
10% Owner
2021-10-26 16:51:39166,423
0
166,423Form 4
Huber Martin H. Jr.
PRESIDENT AND HEAD OF R&D
2023-08-18 20:30:10136,500
0
136,500Form 4
TOMLINSON SIMON M
10% Owner
2021-10-21 20:52:00131,117
0
131,117Form 3
CLACKSON TIMOTHY P
10% Owner
2021-10-21 20:52:2640,863
70,888
111,751Form 3
Williams John Charles
10% Owner
2021-10-22 20:16:11100,080
0
100,080Form 3
Estate of Ulrich Rodeck
10% Owner
2021-10-21 20:53:12100,080
0
100,080Form 3
Luptakova Katarina
CHIEF MEDICAL OFFICER
2024-05-03 16:10:2759,333
0
59,333Form 4
HUMPHREY RACHEL
Director
2021-10-21 20:41:1558,133
0
58,133Form 3
Brennan Aoife
Director
2024-06-17 16:10:4150,000
0
50,000Form 4
Shannon James Samuel
Director
2024-06-17 16:12:4950,000
0
50,000Form 4
Giovine Salvatore
CHIEF FINANCIAL OFFICER
2022-02-24 17:30:3449,500
0
49,500Form 4
ROSS ROBERT W.
Director
2024-06-17 16:30:1525,000
0
25,000Form 4
Clancy Paul J
Director
2024-06-17 16:30:0925,000
0
25,000Form 4
Bonstein Sara
Director
2024-06-17 16:30:1825,000
0
25,000Form 4
Rossi Christina
Director
2024-06-17 16:30:1225,000
0
25,000Form 4
Xu Yuan
Director
2024-06-17 16:30:2225,000
0
25,000Form 4
Curran Daniel J.
Director
2024-06-17 16:30:0825,000
0
25,000Form 4
English Edward C
PRINCIPAL ACCOUNTING OFFICER
2023-01-04 16:09:0624,000
0
24,000Form 4
Brennan Kevin M.
SVP, FINANCE AND ACCOUNTING
2024-05-03 16:10:2020,000
0
20,000Form 4
Heyman Tomas J.
Director
2023-06-13 16:30:3513,200
0
13,200Form 4
Ross Michael Jay
Director
2022-06-17 16:30:5013,200
0
13,200Form 4
Flynn James E
Deerfield Mgmt L.P.
DEERFIELD PARTNERS L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Mgmt V L.P.
Possible Member of 10% Group
10% Owner
2022-12-29 17:24:090
0
0Form 13G